Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001102624-14-002058
Filing Date
2014-12-22
Accepted
2014-12-22 17:10:02
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 AEOLUS PHARMACEUTICALS, INC. 10-K aeolus10k.htm 10-K 1792891
2 EXHIBIT 21.1 exh21_1.htm EX-21.1 1984
3 EXHIBT 23.1 exh23_1.htm EX-23.1 3411
4 EXHIBIT 31.1 exh31_1.htm EX-31.1 14530
5 EXHIBIT 31.2 exh31_2.htm EX-31.2 16729
6 EXHIBIT 32.1 exh32_1.htm EX-32.1 12421
7 IMAGE aeolusimage1.jpg GRAPHIC 49308
8 IMAGE aeolusimage2.jpg GRAPHIC 32201
9 IMAGE aeolusimage3.jpg GRAPHIC 68052
10 IMAGE aeolusimage4.jpg GRAPHIC 59349
11 IMAGE aeolusimage5.jpg GRAPHIC 43091
  Complete submission text file 0001102624-14-002058.txt   2191105
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50481 | Film No.: 141303753
SIC: 2834 Pharmaceutical Preparations